Mitochondrial Disease: Translating Biology into New Treatments
Conference - Hinxton, Cambridge, United Kingdom
The last two decades have seen the emergence of mitochondrial medicine as a distinct clinical discipline. Mitochondrial disorders are notoriously difficult to diagnose and treat – but there has been a paradigm shift within the last year. The prospect of a molecular diagnosis for all patients, coupled with advances in understanding pathophysiology and treatments, has moved the field into a new “translational era”.
This exciting new conference will bring together world leaders in the field of translational mitochondrial medicine. The interactive programme is designed to engage and inspire a new generation of mitochondrial researchers, who will harness this new technology to prevent and treat these devastating diseases.
Sessions will include:
• Delivering a comprehensive molecular diagnosis for mitochondrial disorders
• Clinical mitochondrial medicine: evolving disease phenotypes
• What causes cell dysfunction and cell death?
• Finding new treatments
• Pre-clinical treatment studies in mitochondrial disease
• Recent success treating and preventing disease
Organization: Wellcome Trust
(Courtesy of mitochondrial disease, via scientificamerican.com)
Mitochondrial Disease: Translating Biology into New Treatments
October 2, 2013 - October 4, 2013
Wellcome Trust Conference Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
Contact: scientificconferences@ hinxton.wellcome.ac.uk
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
